Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study by Noristani, H N et al.
Increased hippocampal CA1 density of serotonergic
terminals in a triple transgenic mouse model of
Alzheimer’s disease: an ultrastructural study
HN Noristani
1, RS Meadows
1, M Olabarria
1, A Verkhratsky
1,2,3 and JJ Rodrı ´guez*
,2,3,4,5
Alzheimer’s disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions
including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT
transporter(SERT)ﬁbredensityinthehippocampalCA1inanADtripletransgenicmousemodel(3xTg-AD). Here,weanalysethe
ultrastructural localisation, distribution and numerical density (Nv) of hippocampal SERT axons (SERT-Ax) and terminals (SERT-
Te) and their relationship with SERT ﬁbre sprouting and altered synaptic Nv in 3xTg-AD compared with non-transgenic control
mice. 3xTg-AD animals showed a signiﬁcant increase in SERT-Te Nv in CA1 at both, 3 (95%) and 18 months of age (144%), being
restricted to the CA1 stratum moleculare (S. Mol; 227% at 3 and 180% at 18 months). 3xTg-AD animals also exhibit reduced Nv of
perforated axospinous synapses (PS) in CA1 S. Mol (56% at 3 and 52% at 18 months). No changes were observed in the Nv of
symmetric and asymmetrical synapses or SERT-Ax. Our results suggest that concomitant SERT-Te Nv increase and PS
reduction in 3xTg-AD mice may act as a compensatory mechanism maintaining synaptic efﬁcacy as a response to the AD
cognitive impairment.
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Alzheimer’s disease (AD) is an age-related, irreversible and
progressive neurodegenerative disease that deteriorates
memory and cognition.
1 Neuropathological hallmarks of AD
include neuritic plaques (amyloid beta (Ab)), neuro-ﬁbrillary
tangles, neuronal death and synaptic loss, which occurs early
in AD, and is linked to impaired synaptic connectivity and
plasticity.
2,3
Although, AD affects primarily the cholinergic system,
4
other neurotransmitter systems are also implicated such as
glutamate
5 and serotonin (5-HT).
6,7 Majority of 5-HT neu-
rones are located within the dorsal and median raphe nuclei
projecting to numerous brain regions including the thalamus,
amygdala, cortex and the hippocampus, where they have
important role in mnesic and cognitive functions.
8,9 AD
patients exhibit reduced 5-HT neurotransmission, which
correlates with disease severity.
10 Treatment with selective
serotonin re-uptake inhibitors (SSRIs) and speciﬁc 5-HT
receptor ligands improves cognition in AD patients.
6
The degree and importance of changes in the 5-HT system
in AD remains elusive in human studies, however, experi-
ments on animal models indicate its pathological relevance.
APPswe/PS1DE9 double transgenic mice display degeneration
of 5-HT ﬁbres, while APPSw,Ind transgenic mice overexpres-
sing APP Swiss/Indian mutations show stable 5-HT ﬁbre
density in parietal cortex and the hippocampus.
11,12 However,
subsequent study in APPswe/PS1DE9 transgenic mice re-
vealed no alterations in 5-HT transporter binding sites
(measured using [
3H]-escitalopram radioligand) up to 11
months of age despite Ab accumulation in the cortex and the
hippocampus.
13 Similarly, increased 5-HT ﬁbre sprouting was
reported following neurotoxin lesion and Ab accumulation in
striatumandhippocampus
14–17(seealsoTable1).Inaddition,
other transgenic mice (APP-23) show aberrant non-5-HT
hippocampal axonal sprouting, which is directly related to Ab
accumulation.
18 Serotonintransporter(SERT) isexpressedin
serotonergic axons and axonal terminals being critical for
5-HT re-uptake.
19 Recently, we reported increased hippo-
campal SERT-immunoreactive (SERT-IR) ﬁbres density in
the triple transgenic (3xTg-AD) mouse model of AD,
7 which
mimics the spatiotemporal pathology and mnesic alterations
of AD.
20 Interestingly, the increase in SERT-IR ﬁbre density is
more evident in proximity to amyloid plaques suggesting that
aberrant SERT-IR axonal sprouting and amyloid deposition
are closely linked in AD neuropathology.
7
Studies of synaptic density in AD patients and transgenic
mouse models of AD also reveal inconsistent results.
Whereas post-mortem studies show a steady decrease in
synapses,
21,22 different transgenic mouse models exhibit
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23,24 (see
also Supplementary Table 1). Indeed, 3xTg-AD mice show no
changes in total synapse density
25 although the numerical
density (Nv) of hippocampal perforated axospinous synapses
seems to be reduced.
26
We recently reported increased SERT-IR ﬁbre density in
the CA1 stratum lacunosum moleculare (S. Mol) of the
hippocampus in 3xTg-AD mice.
7 This increase in SERT-IR
ﬁbre density initially appears at 3 months, which is in parallel
with the evident intraneuronal accumulation of Ab.
7,20 How-
ever, SERT-IR ﬁbre density between 6, 9 and 12 months of
age, is comparable to non-transgenic (non-Tg), while there is
alatesproutingrecurrenceat18months,concomitantwiththe
build-up of large extracellular neuritic plaques in 3xTg-AD
animals.
7,20 In this study, we extend our previous ﬁndings by
analysing the ultrastructural changes in hippocampal SERT
axons (SERT-Ax), terminals (SERT-Te) and their association
with synaptic Nv and connectivity in the hippocampus in 3xTg-
AD compared with non-Tg control, by using a quantitative
three-dimensional immunoperoxidase method, at these two
ostensibly key points in either the start-up of anomalous intra-
neuronalAbaccumulation(3months)andtheconsolidation of
Ab neuropil plaque formation and aggregation (18 months).
Results
At light microscopic level, in both 3xTg-AD and non-Tg control
animals SERT-immuoreactive (SERT-IR) ﬁbres were hetero-
geneously distributed throughout the hippocampal formation
(Figures 1, 2a and b). SERT-IR ﬁbres appeared mainly as ﬁne
and thick processes with numerous varicosities, which are
characteristic of axonal proﬁles (Figures 1c, d, 2a and b). The
highestdensitiesofSERT-IRﬁbresareevidentintheS.Molof
CA1area(Figures1c,d,2aandb).Strataradiatumandoriens
exhibited moderate expression while the lowest densities of
SERT-IR ﬁbres are present in the stratum pyramidale (S. Py).
The 3xTg-AD group showed increased density of SERT-IR
ﬁbres in the S. Mol of CA1 exclusively at 3 and 18 months
compared with age-matched controls (Figures 1c, d, 2a
and b),asshownbyaugmentedSERT-IRﬁbreopticalandNv,
which corresponded to our previous and recently described
ﬁndings during the progression of AD.
7 Increased SERT-IR
ﬁbre density, in 3xTg-AD, was even more evident in the
proximity of Ab plaques (Figures 2d–f).
Ultrastructural distribution of hippocampal SERT
proﬁles. SERT-EM analysis conﬁrmed that the majority of
SERT-IR proﬁles were small axons and axon terminals and/
or varicosities with different size and morphological features
according to their raphe nuclei origin (Figures 3a, b, d–f and
4c–f).
7 SERT-IR proﬁles were identiﬁed by the presence of
amorphous electron-dense DAB reaction product that was
mainly associated with the plasma membrane of axons and
terminals (Figures 3d–f and 4c–f) with or without association
with the synaptic specialisation (Figure 3a and d–f). From the
17993 axonal proﬁles analysed, 592 (3.3%) contained
peroxidase labelling for SERT. The majority of SERT-IR
proﬁles consisted of morphologically heterogeneous
population of axonal terminals and/or varicosities (SERT-
Te) that made up 81% of the SERT contained proﬁles
(n¼479 out of 592; Figures 3a, b, d–f, 4c–f, 5b–e).
Occasionally, the labelling was directly associated with
cytoplasmic organelles, including dense core vesicles,
which are characteristic of serotonergic terminals
(Figure 3f).
19 Dense labelling for SERT was also observed
in small unmyelinated axons (SERT-Ax), which were
predominantly apposed to other small axons and/or
terminals (Figure 3c). SERT-Ax comprised 17% of the
SERT-IR proﬁles (n¼104 out of 592) and was seldomly in
contact with dendritic proﬁles. SERT labelling was absent in
postsynaptic sites and was rarely observed in glial proﬁles.
From the 479 immuno-labelled SERT-Te identiﬁed in this
study, only 64 (13%) showed synaptic specialisation mostly
represented by asymmetrical synapses with dendritic spines
and dendrites (Figures 3a and b). SERT-Te area varied in
size from 0.12 to 1.01mm
2 (mean 0.2±0.01mm
2). The main
postsynaptic target of SERT-Te terminals were unlabelled
dendrites onto which these terminals establish asymmetrical
Table 1 Summary of studies on 5-HT alterations in animal models of Alzheimer’s disease
AD model Neuropathology
Brain area
investigated 5-HT alteration Reference
APPswe/PS1DE9 Plaques C, Am, H 5-HT ﬁbre degeneration (12 and 18
months)
Liu et al.
11
APPSwe Plaques H Aberrant non-5-HT axonal sprouting
(18–20 months)
Phinney et al.
18
Intrahippocampal Ab(1 40)
injection
Aggregated amyloid
material
H Increased 5-HT activity within the
vicinity of injection site
Verdurand et al.
16
Intrastriatal ibotenic acid
injection
Neurodegeneration S Vigorous sprouting of 5-HT ﬁbres Zhou et al.
17
MBN NMDA injection Increased APP
expression+cholinergic
lesion
MBN Abundant sprouting of 5-HT ﬁbres
within damaged area
Harkany et al.
14
MBN Ab(1 42) injection Cholinergic lesion MBN 5-HT ﬁbre sprouting Harkany et al.
15
APPswe/PS1DE9 Plaques FC, PreC, H No change Holm et al.
13
hAPPSw,Ind Plaques H No change Aucoin et al.
12
3xTg-AD Plaques and tangles H Biphasic 465% increased SERT-
Fibre density (3 and 18 months)
Noristani et al.
7
Abbreviations: Am, Amygdala; APP, amyloid precursor protein; C, cortex; FC, frontal cortex; H, hippocampus; MBN, magnocellular nucleus basalis; NMDA,
N-methyl-D-aspartate, PreC, prefrontal cortex; S, striatum
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Cell Death and Diseasesynapses, which sometimes localised in a close vicinity to
glutamatergic excitatory synapses (Figures 3a, 4c–f, 5b–e).
Temporal changes in SERT-Te Nv and size in 3xTg-AD
mice. We observed an increase in SERT-Te Nv in the
CA1 subﬁeld of the hippocampus in a strata-speciﬁc
manner (Figures 4a and b). The global analysis showed a
signiﬁcant increase in SERT-Te Nv at 3 and 18 months
in 3xTg-AD compared with control group (95%, P¼0.0436
and 148%, P¼0.0064, respectively; Figure 4a). A more
detailed quantitative analysis of CA1 individual
strata revealed that the increased SERT-Te Nv was
restricted to the CA1 S. Mol, which also exhibited the
highest density of SERT-IR ﬁbres within the hippocampal
formation in basal conditions (Figures 1c, d, 2a and b). This
increase also appeared at the same ages doubling or almost
doubling the values from age-matched control mice (227%,
P¼0.0148 at 3 months, and 180%, P¼0.0329 at 18 months;
Figure 4b). SERT-Te Nv showed no alterations in either
stratum oriens (S. Or) or stratum radiatum (S. Rad) at any
examined age (P¼0.5659, P¼0.1948 for S. Or and
P¼0.0571, P¼0.2607 for S. Rad at 3 and 18 months,
respectively; data not shown). The increase in SERT-Te Nv is
associated with a generalised increase in their size as
measured by determining their area, which was age speciﬁc
(by 108%, P¼0.0264 at 3 months and by 89%, P¼0.0474,
at 18 months; Figures 5a–e) but not strata speciﬁc. No age-
associated changes were observed in either SERT-Te Nv or
their size in 3xTg-AD animals between 3 and 18 months of
age. However, non-Tg animals showed an age-associated
decrease in SERT-Te Nv in the CA1 of the hippocampus
(39% decrease, P¼0.0413) although their size remain
stable (Figures 4a and 5a). In addition, SERT-Ax Nv and
size remained stable in 3x-Tg-AD and non-Tg control in all
strata and examined ages.
Reduced Nv of perforated synapses in the hippocampus
of 3xTg-AD mice. Synaptic elements and postsynaptic
densities were heterogeneously distributed throughout the
different hippocampal layers (Figures 3b, e, 4c–f, 5b–e) as
revealed by the use of serial EM sections, which allowed us
to distinguish and quantify different synapse populations,
according to their postsynaptic densities and synaptic
vesicles composition (see Supplementary Figure S1).
Symmetric synapses have thin pre- and postsynaptic
densities with axons containing pleomorphic (round and
elongated) synaptic vesicles (Supplementary Figure S1A),
while asymmetric synapses displayed round synaptic
vesicles in the axons and were characterised by the
presence of a thin presynaptic density and with a thick and
more prominent postsynaptic membrane specialisation
27
(Supplementary Figure S1B). Some of these asymmetric
synapses presented a notable discontinuity (450nm) in the
electron density of the postsynaptic junction as previously
described
27 being considered as perforated (Supplementary
Figure S1C). The majority of the total unlabelled (SERT
 )
identiﬁed synapses were asymmetric being characterised by
a thin pre- and a thick postsynaptic membrane specialisation
(Figures 3e and e). In total, 11108 SERT
  synapses were
identiﬁed of which 10889 (98.03%) were asymmetrical type
between axons and dendritic spines; the remaining 219 (2%)
were symmetrical synapses mainly established onto
dendrites and dendritic shafts (Figure 3a). Only 7.9% (863)
of the asymmetric synapses were identiﬁed as perforated.
Although, global analysis ofhippocampal CA1 areashowed
nodifferenceinNvoftotal,symmetricandasymmetric SERT
 
Figure 1 Brightﬁeldmicrographsillustratingthedistributionof SERT-IRﬁbresinthedorsalhippocampusof 3monthsoldnon-Tgcontrol(a)and3xTg-ADmice(b)andthe
respective high magniﬁcation details of the CA1 subﬁeld area of the hippocampus that was selected for the electron microscopic analysis (c and d). Hippocampal sections
were selected at identical anatomical levels between the different animals to ensure an exact and equivalent sampling. Scale bar 500mm( a and b), 100mm( c and d). DG,
dentate gyrus
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Cell Death and Diseasesynapses; there was a signiﬁcant decrease in perforated
axospinous Nv in 3xTg-AD compared with non-Tg control
(Figure 6c). Analysis of the whole hippocampus revealed
signiﬁcant decrease in perforated axospinous Nv in 3xTg-AD
animalsat3butnotat18monthsofage(64%loss,P¼0.0056
and 39% loss, P¼0.1453). The layer-speciﬁc analysis also
revealed that the S. Mol exhibits signiﬁcant deﬁcit in Nv of
perforated axospinous synapses (Figure 7c) at 3 and 18
months compared with age-matched control (56% loss,
P¼0.0260 and 50% loss, P¼0.0394). Furthermore, the
non-Tg control group also showed an age-associated
decrease in perforated axospinous Nv both in CA1 subﬁeld
of the hippocampus and S. Mol of the CA1 (38% loss,
P¼0.0260 and34% loss, P¼0.0070, Figures 6cand 7c), this
was not the case for Nv of other types of SERT
  synapses.
However, we did not ﬁnd any changes in the synaptic Nv
speciﬁcally established by SERT-labelled (SERT
þ) proﬁles
when comparing 3xTg-AD with non-Tg animals either in the
whole CA1 subﬁeld or S. Mol (P¼0.4796, P¼0.3739 at 3
months and P¼0.1529, P¼0.5185 at 18 months, respec-
tively (Figures 6d and 7d). SERT
þ synapses were mainly
asymmetric synapses with dendritic spines and dendrites.
Figure 2 Brightﬁeld micrographs showing SERT-IR ﬁbres in the dorsal hippocampus of 18 months old non-Tg control (a) and 3xTg-AD mice (b). Dual confocal
micrographsshowingSERT-IRﬁbresinthedorsalhippocampusof18monthsoldnon-Tgcontrol(c),anda3xTg-AD(d),thelattercontainingAbplaques(e)showingSERT-IR
ﬁbres speciﬁc sprouting adjacent to Ab plaques within the CA1 subﬁeld of the hippocampus in a 18 month 3xTg-AD animal (f, merged image). Scale bar 100mm( a and b),
25mm c, d, e and f. f, hippocampal ﬁssure
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Cell Death and DiseaseUltrastructuralanalysisofSERT
þ synapticspecialisationalso
showed no difference in SERT
þ axo-spine and axo-dendritic
synapses between 3xTg-AD and non-Tg control animals.
Discussion
Age-dependent and CA1 strata-speciﬁc increase in
SERT terminals. Our main ﬁnding is that 3xTg-AD mice
display an age-dependent increase in Nv of SERT-IR
terminals. Global quantitative analysis of hippocampal CA1
revealed that SERT-Te Nv is increased at 3 and 18 months
when compared with age-matched non-Tg controls. The
increase in SERT-Te Nv is more evident within the S. Mol of
CA1 area, which in normal conditions is also known to host
the highest density of serotonergic projections in the
hippocampal formation.
8 In addition, to the increased Nv
the size of SERT-Te was also increased in the CA1 subﬁeld
of the hippocampus. No changes were observed in SERT-Ax
Nv. These data suggest that there is an age-dependent
increase in hippocampal serotonergic input that is closely
associated with development of AD pathology in 3xTg-AD.
Furthermore, our ﬁnding of increased SERT-Te Nv conﬁrm
our previous hypothesis of SERT ﬁbres sprouting in the CA1
S. Mol of the hippocampus (as shown by increased optical
and Nv of SERT-IR ﬁbres) at 3 and 18 months 3xTg-AD mice
compared with age-matched non-Tg control animals.
7
Serotonergic ﬁbre sprouting is generally deﬁned as ﬁbre
outgrowth reﬂected by increase in size and diameter of
axons, appearance of new spindle varicosities with no sign of
damaged SERT axons.
7,14,17 Serotonergic ﬁbre sprouting
may act as a compensatory mechanism by maintaining an
overall stable hippocampal circuitry and synaptic
connectivity. Thus, our results provide the ﬁrst
ultrastructural evidence for increased serotonergic input
within the hippocampus of 3xTg-AD mouse model.
Previously, increased 5-HT ﬁbre sprouting was found only
after acute brain damage such as Ab, ibotenic acid and
NMDA injections in rats (Table 1).
14–17 Similar changes in
non-5-HT ﬁbre sprouting were observed in the entorhinal
cortex and thalamic nucleus in the APP23 transgenic mice.
18
In 3xTg-AD mice, intracellular Ab accumulation starts at an
early age (3 months) that may also cause early damage to the
affected neurones.
28 Extracellular deposition of Ab1 42
contributes to plaque formation, which in 3xTg-AD begins
between 9 and 12 months of age and consolidates at 18
months, primarily targeting the CA1 hippocampal subﬁeld and
in particular stratum moleculare.
7,20 The 3xTg-AD mice
exhibit age-related increase in extracellular build-up of
plaques that continues into advanced age.
20 Indeed, previous
studies including our recent studies in the same cohort of
animalsconﬁrmedthatthe3xTg-AD animalsexhibitextensive
Ab and tau pathology at 18 months of age
7,20 (see also
Figure 2e). Such massive build-up and consolidation of
Figure3 ElectronmicrographsshowingmorphologicalfeaturesofSERTaxonterminals(SERT-Te)andSERTsmallaxons(SERT-Ax)inthehippocampalCA1subﬁeldof
18 months old 3xTg-AD (a and b), 3 months old non-Tg control (c and e) and 18 months old non-Tg control (d and f). A: Peroxidase labelling for SERT-Te is seen within
multiple terminals (T1-3) in the pyramidal cell layer of the hippocampus. One of them (SERT-T1) is forming an asymmetrical synapse (curved arrow) with an unlabelled
dendrite (UD). (b) Immunoperoxidase labelling of two SERT-Te (T1-2) in the CA1 S. Mol, establishing two asymmetrical synaptic contacts (curved arrows) with an unlabelled
dendrite(UD).(c)SERTplasmalemmallabellinginasmallunmyelinatedaxon(SERT-Ax)intheCA1S.Mol,whichisapposedtoanunlabelledterminal(UT)andanunlabelled
dendritic spine (usp). (d–f) SERT immunoreactivity in small (d) and large axon terminals (e and f) in the CA1 S. Mol, showing in some cases the characteristic dense core
vesicles (DCVs) of serotonergic terminals (f) and forming asymmetricsynapses (curved arrows). Scale bar 500nm (a–f). M, mitochondria; rER, rough endoplasmic reticulum;
Nu, nucleus; UD, unlabelled dendrites; usp, unlabelled spine; UT, unlabelled axon terminal; UA, unlabelled axon
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Cell Death and Diseaseplaques at a later age (18 months) may induce neurotoxic
effects resulting in neuronal damage that in turn may also
stimulate an increase in SERT-Te in 3xTg-AD.
7 Lack of SERT
ﬁbre sprouting at earlier ages (6 to 12 months) in 3xTg-AD
animals may be due to lower level of extracellular amyloid
accumulation in CA1 of the hippocampus, as well as to a less
compromised synaptic connectivity compared with 18
months.
7 In agreement with this phenomenon, a recent study
in the Ab APPswe/PS1DE9 double transgenic model with
associated severe amyloid pathology showed no alteration
in cortical and hippocampal SERT density up to 11 months of
age.
13 In addition, our preliminary results suggest that SERT-
IR ﬁbre sprouting is further increased in the hippocampus at
24 months of age in 3xTg-AD animals, concomitant with
formation of large extracellular Ab plaques (Noristani et al.,
7
unpublished observation). Furthermore, our ﬁnding of early
increase in SERT-Te (3 months) may indicate that this
process could even start with the accumulation of intracellular
Ab1 42,
20 which in turn might account for an initial protective
response to restore hippocampal functionality.
7
The neurotoxic effect of Ab involves increased activation of
glutamatergic neurotransmission and impairment of calcium
homeostasis.
29 Increased 5-HT input may help to counteract
neurotoxicity by inhibiting calcium inﬂux and inducing mem-
brane hyperpolarisation.
14,15 This effect is mediated by
activation of 5-HT1A and 5-HT1B receptors that are highly
expressedinthe hippocampal formation.
30,31 In supportofthe
above hypothesis, a recent study by Verdurand et al.
16
reported enhanced 5-HT neurotransmission and 5-HT1A
receptors expression following intrahippocampal infusion of
Figure 4 BargraphsshowingtheageeffectonSERT-TeNv withinoverallCA1subﬁeldofthehippocampus(a)andstratummoleculareoftheCA1(b)at 3and18months
in non-Tg control and 3xTg-AD.Bars representmean±S.E.M.*Po0.05, **Po0.01 comparedwith age-matchednon-Tg control,
#Po0.05 compared with 3 monthsnon-Tg
control. (c–f) Representative electron micrographs illustrating SERT-Te density in the CA1 stratum moleculare subﬁeld of the hippocampus at 3 and 18 months in non-Tg
control (c and e) and 3xTg-AD mice (d and f). Scale bar 500nm (c–f). M, mitochondria
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Cell Death and DiseaseAb. Increased expression of hippocampal 5-HT1A receptors
was also reported in patients with mild cognitive impairment
who exhibit greater risk of developing AD.
32 Therefore, an
increased 5-HT input may represent an intrinsic protective
mechanism in response to Ab-induced excitotoxic damage.
7
In fact, increased SERT-Te area in 3xTg-AD suggests that
these terminals might release greater quantities of neuro-
transmitter, thus enhancing the synaptic strength.
Wehave also observed a pronouncedincrease inSERT-Te
Nv in the S. Mol. Such layer-speciﬁc effect may be due to the
highest density of 5-HT projections compared with other
hippocampal layers.
8 In addition, and as mentioned earlier, in
3xTg-AD animals excess extracellular Ab plaques are evident
inthe S.Mol.
7 Thiscombined phenomenonwould accountnot
only for the SERT-IR ﬁbres sprouting but also directly affect
the synaptic density and connectivity in the hippocampus.
AD-associated changes in synaptic density. Contrary to
the accepted phenomenon linking AD to synaptic loss, we
found no overall deﬁcit in synaptic Nv in the hippocampal
CA1 subﬁeld.
3,22 Our results are in agreement with previous
studies, which, by employing qualitative or semi quantitative
light immunohistochemistry, reported no overall changes in
synaptic-associated proteins such as synaptophysin in the
hippocampus and in the cortex of APP23, PDAPP, PSAPP,
APPSw and recently in 3xTg-AD animals (see Supplementary
Table 1). Similarly, no changes in total Nv of synapses were
observed in the pyramidal layer of the hippocampal CA1 in
3xTg-AD animals at 13 months of age.
26 We further extend
this ﬁnding by analysing all the strata in 3xTg-AD animals up
to 18 months of age. Although we found no changes in the
overall synaptic Nv, there was a decrease in the Nv of
perforated axospinous synapses in the CA1 area of the
hippocampus and more speciﬁcally in the S. Mol that was
evident at early age (3 months, 56%) and continued into
advanced age (18 months, 52%). Our analysis has also
shown that this synaptic population is affected during aging.
The age-related decrease is consistent with previous results
in aged rats in which hippocampal perforated synapses
showed decrease in Nv and a reduction in the size of
postsynaptic density
33,34 although others have reported no
changes in total number of all perforated and non-perforated
axospinous synapses.
35 One factor that may account for this
discrepancy includes variations in hippocampal volume.
35
Figure5 BargraphsshowingtheageeffectonSERT-TeareaintheCA1subﬁeldofthehippocampus(a)at3and18monthsinnon-Tgcontroland3xTg-ADanimals.Bars
represent mean±S.E.M. *Po0.05. (b–e) Representative electron micrographs of the SERT-Te area in the CA1 subﬁeld of the hippocampus in 3xTg-AD animals (c and e)
compared with non-Tg control mice (b and d). Scale bar 500nm (b–e). M, mitochondria
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Cell Death and DiseaseFigure 7 Bar graphs showing the age effect on unlabelled (SERT
 ) total (a),
asymmetrical (b), and perforated synapses (c) as well as the speciﬁc synaptic Nv of
SERT-labelled (SERT
þ) proﬁles (d) at 3 and 18 months in non-Tg control and
3xTg-AD in the CA1 S. Mol of the hippocampus. Bars represent mean±S.E.M.
(n¼3). *Po0.05,
##Po0.01
Figure 6 Bar graphs showing the age effect on unlabelled (SERT
 ) total (a),
asymmetrical (b), and perforated synapses (c) as well as the speciﬁc synaptic Nv of
SERT-labelled (SERT
þ) proﬁles (d) in the CA1 of the hippocampus at 3 and 18
months in non-Tg control and 3xTg-AD group. Bars represent mean±S.E.M.
**Po0.01,
#Po0.05
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Cell Death and DiseaseConﬂicting results have been reported in relation to
hippocampal volume alterations in different transgenic
models of AD.
36–40 Previous studies in single and double
transgenic mouse models of AD including (PS1, APP/PS-1
and PSAPP mice) showed no alterations in hippocampal
volume using longitudinal in vivo MRI scanning
36 or
Cavalieri’s principle for estimation of total hippocampal
volume.
37,38 Contrary, Oberg et al.
39 reported decreased
hippocampal volume in APP/PS1 double transgenic mice
using in vivo longitudinal MRI scanning. On the other hand,
Maheswaran et al.
40 have demonstrated increased
hippocampal volume in the TASTPM mice showing severe
amyloidosis, which could be associated with an accumulation
of amyloid plaques and reactive glial cells. In this study, we
analysed an equal hippocampal volume between 3xTg-AD
and non-Tg control animals, which reliably eradicates the
effect of possible volume alterations on synaptic Nv.
35,41 In
addition, ultrathin section series were cut at a constant
thickness (see Materials and methods section) between the
two groups to avoid the bearing effect of section thickness on
synaptic Nv.
41 Furthermore, the criteria we used for synapse
determination includes not only the presence of postsynaptic
density but also the occurrence of the adjacent presynaptic
element containing the synaptic vesicles, which provides a
reliable and un-biased estimation of synaptic Nv compared
with that of just proﬁle count.
41 Finally, and in parallel with the
report in the majority of AD transgenic models, our ﬁndings
are consistent with a recent electron microscopic study that
also reported reduced Nv of perforated synapses in 3xTg-AD,
when quantifying synapses per unit volume.
26
Perforated axospinous synapses in the hippocampus have
an important role in spatial and working memory.
33,34
Increased perforated synapses have been linked with the
induction of long-term potentiation and enhanced memory
performance in rodents.
42 Reduced perforated synapses
show good correlation with deterioration of cognitive function
including learning and memory.
33,34 Given the pivotal role of
perforated axosinous synapses in cognitive function, the
reduced Nv of perforated synapses that we have found may
reﬂect the impaired synaptic plasticity and subsequent
deterioration of learning and memory in 3xTg-AD ani-
mals.
20,26 In this direction, post-mortem studies on human
tissue have consistently reported a decrease in synaptic
density in the cortex and in the hippocampus.
21,22 In
transgenic models, which exhibit plaque pathology, both an
increase and a decrease in synaptic density was found in the
neocortex and in the hippocampus.
23,24 Transgenic models
with tangle pathology have also showed reduced hippocam-
pal synaptic density
43 (see also Supplementary Table 1).
Different factors may account for these controversies includ-
ing differences in (i) transgenic models (ii) strains, (iii) age,
(iv) brain area studied and (v) methods used to quantify
synaptic density.
41
In conclusion, this study suggest that sprouting of seroto-
nergic axons is directly related with an increased Nv and area
of SERT-Te that may act as a compensatory mechanism in
maintaining overall synaptic efﬁcacy. In addition, this in-
creased serotonergic input may be an intrinsic neuroprotec-
tive response to counteract Ab-induced neurotoxicity and
altered hippocampal glutamatergic circuitry, as revealed by
the decrease in asymmetric perforated Nv, accounting for the
early behavioural alterations and later establishment of
severe and permanent cognitive and mnesic impairments in
AD. In fact, enhanced 5-HT neurotransmission via chronic
treatment with SSRI (paroxetine) improves memory perfor-
mance and retards the development of amyloid and tau
pathologies in 3xTgAD mice.
44 Thus, increasing 5-HT
neurotransmission in AD may provide a better therapeutic
approach not only to improve behavioural abnormalities, but
also to interfere with underlying neuropathology associated
with AD.
Materials and Methods
All animal procedures were carried out in accordance with the United Kingdom
Animals(ScientiﬁcProcedures)Actof1986underthelicensefromtheHomeOfﬁce.
All efforts were made to reduce the number of animals by following the 3Rs.
Animals. The procedures for generating 3xTg-AD mice have been described
previously.
7,20 In brief, human APP cDNA harbouring the Swedish mutation
(KM670/671NL) and human four repeat Tau, harbouring the P301L mutations were
co-microinjected into single-cell embryos of homozygous PS1M146V knockin mice.
The background of the PS1 knockin mice is a hybrid 129/C57BL6. The non-Tg
control mice used were also from the same strain and genetic background as the
PS1knockinmice,buttheyharbourtheendogenouswild-typemousePS1gene.All
3xTg-AD and non-Tg mice were obtained by crossing homozygous breeders. The
animals were housed in the same-sex cage, kept in 12-h light–dark cycles with free
access to food and water.
Fixation and tissue processing. Male 3xTg-AD and their respective non-
Tgcontrolswereanaesthetisedwithintraperitonealinjectionofsodiumpentobarbital
(50mg/kg)at3and18monthsofage(n¼3).Micewereperfusedthroughtheaortic
arch with 3.75% acrolien (TAAB, Berkshire, UK) in a solution of 2%
paraformaldehyde (Sigma, Gillingham, UK) and 0.1M phosphate buffer (PB) pH
7.4, followed by 2% paraformaldehyde. Brains were then removed and cut into
4–5mm coronal slabs of tissue consisting of the entire rostrocaudal extent of the
hippocampus, as described previously.
7 The brain sections were post-ﬁxed in 2%
paraformaldehyde for 24h and kept in 0.1M PB, pH 7.4. Coronal sections of the
brain were cut into 40–50mM thickness using a vibrating microtome (VT1000S,
Leica, Milton Keynes, UK). Free ﬂoating brain sections in 0.1M PB, pH 7.4 were
collected and stored in cryoprotectant solution containing 25% sucrose and 3.5%
glycerolin0.05M PBat pH 7.4.Coronalvibratomehemisectionsatlevel  2.06mm
posteriortoBregma(dorsalhippocampus),wereselectedforimmunohistochemistry
according to the mouse brain atlas of Paxinos and Franklin.
45 To optimise the
penetration of immunoreagents, the tissue sections were freeze-thawed as
described previously.
27 For this procedure, the sections were (i) incubated in
cryoprotectantsolution containing25% sucroseand 3.5% glycerolin 0.05M PB,pH
7.4, (ii) rapidly immersed in chlorodiﬂuoromethane, followed by liquid nitrogen and
(iii) placed in 0.1M PB at room temperature to thaw the tissue. Then the sections
were rinsed in 0.1M PB, followed by 0.1M Trizma base saline (TS), pH 7.6.
Antibodies. A polyclonal rabbit antibody raised against a synthetic peptide
sequence corresponding to amino acids 602–622 of rat 5HT transporter
(Immunostar, Hudson, WI, USA) was used for determination of SERT-positive
axons and terminals in the hippocampus. For the identiﬁcation of Ab plaques, we
used a monoclonal mouse antiserum monoclonal antibody against amino acid
resides1–16of betaamyloid(Covance,Emeryville, CA,USA).Thespeciﬁcityofthe
antibody has been reported previously using immunohistochemistry
7 and western
blots.
46Tofurtherdeterminethespeciﬁcityoftheantibody,adsorptioncontrolswere
done using SERT peptide, which resulted in total absence of target labelling.
Furthermore, omission of primary and/or secondary antibody also showed no
immunoreactivity (data not shown).
Immunohistochemistry. The sections were incubated for 30min in 30%
methanol in 0.1M PB and 3% hydrogenperoxide (H2O2; Sigma). Sections were then
rinsed with 0.1M PB for 5min and placed in 1% sodium borohydride (Aldrich,
Gilligham, UK) for 30min. The sections were then washed with PB profusely before
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bovineserumBSA (Sigma) in0.1M TSand 0.25% Triton (Sigma,  100)for 30min.
Sectionswereincubatedfor48hatroomtemperatureinprimaryantibody(rabbitanti-
SERT, 1:2500, Immunostar). The sections were rinsed in 0.1M TS for 30min and
incubated in 1:400 dilutions of biotinylated donkey anti-rabbit IgG (Jackson
Immunoresearch, Stratech Scientiﬁc Ltd, Soham, UK) for 1h at room temperature.
Sections were rinsed with 0.1M TS for 30min followed by incubation for 30min in
avidin–biotin peroxidase complex (Vector Laboratories Ltd, Peterborough, UK). The
peroxidase reaction product was visualised by incubation in a solution containing
0.022% of 3,30diaminobenzidine (DAB, Aldrich) and 0.003% H2O2 for 6min as
described previously.
7 The reaction was stopped by rinsing the sections in 0.1M TS
for 6min followed by 0.1M PB for 15min.
For detection and determination of SERT-IR ﬁbre and its relationship with Ab
senile plaques, we used dual indirect immunoﬂuorescence labelling. The sections
wereincubatedfor48hatroomtemperatureinprimaryantibodycocktailcontaining:
(i)mouseanti-bamyloidmonoclonalantibody(Ab;1:2000;Covance)and(ii)rabbit
anti-SERT polyclonal antibody (1:2500, Immunostar) simultaneously. Subse-
quently, Ab plaques and SERT-IR ﬁbres were detected in a sequential manner on
thesamesectionsbyincubationwithAlexa595goatanti-mouseandAlexa488goat
anti-rabbit (Invitrogen, Paisley, UK) IgG, respectively. Finally, sections were rinsed
with 0.1M PB for 30min and permanently mounted in an aqueous medium
(Vectashield; Vetor Laboratories Ltd, Peterborough, UK).
Electronmicroscopy. FollowingtheDABtreatment(immunohistochemistry),
brain sections were rinsed and ﬂattened in 0.1M PB and post-ﬁxed in 2% osmium
tetroxide in 0.1M PB for 1h as described previously.
27,30 The sections were then
washed in 0.1M PB for 10min followed by sequential dehydration through
replacement with graded ethanol series (30, 50, 70 and 95%, 5min each).
Thesectionswerefurtherdehydratedusing100%ethanol(10min),propyleneoxide
(2 15min) and propylene oxide/EPON (1:1, Agar Scientiﬁc Ltd, Stanstead, UK)
overnight at room temperature rotating. The propylene oxide/EPON was replaced
with 100% EPON and rotated for further 2h. The sections were then ﬂat embedded
between sheets of Aclar ﬂuo halocarbon ﬁlm (Agar Scientiﬁc Ltd).
27,30
Polymerisation was carried out by incubating at 601C overnight. Following
polymerisation, the region of interest (CA1 subﬁeld of the hippocampus) was
selectedandmicro-dissected fromtheﬂat-embedded tissueandmountedon thetip
of EPON blocks
27 (Figure 1), keeping the same levels and coordinates between the
differentanimals.Diamondknifewasusedtocutseriesofultrathinsectionsofthese
regions at a thickness of approximately 70nm. Series of sections were collected on
degreased copper mesh grids (200 mesh) and counterstained using uranyl acetate
and lead citrate
47 before examining under Philips FEI Tecnai 12 BioTwin electron
microscope (FEI, Eindhoven, The Netherlands). Random images of the areas of
interest (blindly taken) were collected and the negatives digitalised on an Imacon
Flextight 848 scanner (Imacon Inc. Hasselblad A/S, Copenhagen, Denmark), each
representingavolumeof12.39mm
3,foratotalanalysedCA1volumeof396.48mm
3
(in each animal) and 99.12mm
3 per each CA1 layer (S. Or, pyramidal layer, S. Rad
and S. Mol).
Labelling proﬁles and nomenclature. The labelled proﬁles were
classiﬁed as somata, dendrites, dendritic spines, unmyelinated axons, axon
terminals and glia, according to their morphological features as described
previously
27,30 and deﬁned by Peters et al.
48 Synapses were deﬁned as either
symmetric when having thin pre- and postsynaptic densities or asymmetric when
having a thin pre- and a thick postsynaptic membrane specialisation.
27 Perforated
synapses were deﬁned as those asymmetric synapses with a notable discontinuity
(450nm) in the electron density of the postsynaptic junction as previously
described.
27
Numerical density. To determine the Nv of labelled proﬁles (# labelled
proﬁles/mm
3),ultrastructural analysiswasentirelycarriedoutonthemostsuperﬁcial
portions of the tissue in contact with the embedding plastic; from both vibratome
section sides, to minimise artiﬁcial differences in labelling attributed to potential
differences in the penetration of reagents as described previously.
27 Regions used
for this analysis were chosen randomly by a single investigator without any
informationaboutthegenotypeortheageoftheanimal.TheNvofSERT-Te,SERT-
Ax and synapses was determined, on serial ultrathin sections, according to the
Cavalieri principle as described elsewhere.
49
Nv ¼
X
P=½t   aðpÞ 
Where Nv is the numerical density, SP is the number of SERT-Te, SERT-Ax or
synapses counted; t is the average ultrathin section thickness and a(p) is the
corresponding surface area. All sections used for quantitative analysis were of
identical anatomical level corresponding to  2.06mm posterior to Bregma (dorsal
hippocampus) in both 3xTg-AD and non-Tg control animals.
Three vibratome sections from each of the 12 animals (n¼3 per group) were
examined for ultrastructural quantiﬁcation of SERT immunolabelled proﬁles. The Nv
of labelled proﬁles were determined and identiﬁed by the presence of amorphous
electron-dense DAB reaction product (Figures 3–5). We selected this method over
immunogoldlabelling,becausethelatterislesssensitivecomparedwithperoxidase
labelling.
50 Althoughgoldlabellingallowsamoreselectivesubcellularlocalisation,it
has reduced tissue penetration and limited diffusion that may result in an
underestimation of the relative abundance of immunoreactive proﬁles.
27,50
Furthermore, immunogold labelling provides less reliable quantitative 3D estimation
of labelled proﬁles because it is primarily regarded as 2D (surface) method and is
not reliably considered as quantitative for 3D labelling.
50
The total labelled proﬁles numbered 592 over a corresponding total volume of
4,556.16mm
3. Using computer-assisted imaging analysis (ImageJ 1.32j, NIH,
Bethesda, MD, USA), we also analysed the area of SERT-Te in all hippocampal
layers,as wellas their synapticspecialisations foundin labelled(SERT
þ)terminals
in both 3xTg-AD and non-Tg control animals. Composite ﬁgures, adjusted for
brightness, contrast and sharpness, were generated using Adobe Photoshop CS2
(Adobe Systems Inc., San Jose, CA, USA) and Microsoft Excel 2002 (Microsoft
Corporation, Reading, UK).
Statistical analysis. Results are expressed as mean±S.E.M. Unpaired
Student’s t-test was applied to determine differences in Nv of SERT-Te, SERT-Ax
and synapses between 3xTg-AD and non-Tg control animals at 3 and 18 months of
age. Signiﬁcance was accepted at Pr0.05. The data were analysed using
GraphPad Prism 4.0 (GraphPad Software, Inc., La Jolla, CA, USA).
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